In a 20‑year‑old male chronic alcoholic presenting with icterus, elevated total bilirubin, elevated direct and indirect bilirubin, markedly elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT), normal total protein, albumin, hemoglobin, white blood cell count and platelet count, neutrophil percentage 45.8% and lymphocyte percentage 41.8%, what is the diagnosis and the appropriate treatment with dosages?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Diagnosis: Acute Alcoholic Hepatitis

This 20-year-old male has acute alcoholic hepatitis based on his chronic alcohol use, jaundice, markedly elevated transaminases with AST:ALT ratio >2 (352:696 = 0.5 - wait, this is actually <1, which is atypical but can occur), elevated bilirubin, and absence of other acute complications. 1, 2

Diagnostic Reasoning

The clinical picture strongly suggests alcoholic hepatitis:

  • Jaundice with elevated bilirubin (total 5.3 mg/dL with both direct 2.2 and indirect 3.1 elevated)
  • Elevated transaminases (AST 352 U/L, ALT 696 U/L) - though the AST:ALT ratio here is <1 rather than the typical >1.5-2.0, this can occur in alcoholic hepatitis 2, 3
  • Preserved synthetic function (albumin 4.5 g/dL, total protein 8.1 g/dL)
  • Normal blood counts (Hb 14.1, WBC 8,100, platelets 161,000) suggesting no advanced cirrhosis yet
  • Chronic alcohol use in a young patient

The mixed hyperbilirubinemia pattern (both direct and indirect elevated) is consistent with alcoholic hepatitis, which can present with cholestatic features 4, 5.

Severity Assessment Required

Calculate the Maddrey Discriminant Function (mDF) immediately:

  • mDF = 4.6 × (PT patient - PT control) + Total Bilirubin (mg/dL)
  • You need the prothrombin time/INR to determine severity and treatment eligibility 1

Treatment Algorithm

If mDF ≥32 (Severe Alcoholic Hepatitis):

Before starting treatment, exclude contraindications: 1

  • Screen for infection: chest X-ray, blood cultures, urine cultures, ascites cultures if present
  • Check serum creatinine (contraindicated if >2.5 mg/dL)
  • Rule out active GI bleeding
  • Exclude HBV, HCV, drug-induced liver injury, HCC, acute pancreatitis, HIV, TB
  • Obtain abdominal ultrasound to exclude biliary obstruction

If eligible for treatment:

  • Prednisolone 40 mg orally daily for 28 days (or methylprednisolone 32 mg IV if unable to take oral) 1
  • Consider adding IV N-acetylcysteine (though evidence is mixed, guidelines mention it as an option) 1
  • Enteral nutrition: goal >21 kcal/kg/day 1

Response assessment at Day 7:

  • Calculate Lille score
  • If Lille <0.45: Continue prednisolone for full 28 days
  • If Lille ≥0.45: Stop corticosteroids (non-responder, increased infection risk without benefit)

If mDF <32 (Non-severe):

  • Supportive care only - no corticosteroids indicated 1
  • Nutritional support (>21 kcal/kg/day)
  • Alcohol cessation counseling
  • Monitor closely for complications

Essential Supportive Measures (All Patients)

  • Thiamine 100 mg IV/IM daily then 100 mg oral daily (prevent Wernicke's)
  • Folic acid 1 mg daily
  • Multivitamin supplementation
  • Avoid nephrotoxins: NSAIDs, aminoglycosides, IV contrast 1
  • Cautious diuretic use if ascites develops
  • Lifelong alcohol abstinence - this is critical for survival 1

Critical Missing Information

You must obtain:

  1. PT/INR - essential for calculating mDF and determining treatment eligibility
  2. Serum creatinine - contraindication if >2.5 mg/dL
  3. Abdominal ultrasound - exclude biliary obstruction
  4. Infection screening - blood/urine cultures, chest X-ray

Common Pitfalls

  • Do not start corticosteroids without ruling out infection - this is the most common error and increases mortality 1
  • Do not use corticosteroids if mDF <32 - no benefit, only harm
  • Do not continue corticosteroids beyond 7 days if Lille score ≥0.45 - increases infection risk without survival benefit
  • The atypical AST:ALT ratio (<1 instead of >1.5) does not exclude alcoholic hepatitis, especially with the clear clinical context 4, 5

References

3
Research

Alcoholic hepatitis.

American family physician, 1993

Related Questions

How should a 43-year-old male chronic alcoholic with marked hyperbilirubinemia, elevated γ‑glutamyl transpeptidase, AST approximately twice ALT, low albumin, abdominal pain radiating to the back, and icterus be managed?
In a 33-year-old male alcoholic who stopped drinking 4 days ago, presents with vomiting, hyperbilirubinemia (bilirubin rising from 7 to 9 mg/dL), moderately elevated transaminases, normal INR, and impaired renal function (creatinine decreasing from 3.9 to 2.0 mg/dL) but is asymptomatic, what is the appropriate management?
In a 38-year-old male chronic alcoholic with elevated total bilirubin, elevated alkaline phosphatase, markedly increased direct bilirubin, increased indirect bilirubin, persistent thrombocytopenia, anemia, normal C-reactive protein and erythrocyte sedimentation rate, positive fecal occult blood test, and dengue IgG positivity, what is the likely diagnosis and appropriate management?
In a 38‑year‑old woman with a history of heavy alcohol consumption who presents with right upper‑quadrant pain, jaundice, ascites, elevated AST and ALT, elevated bilirubin, thrombocytopenia, prolonged prothrombin time, negative viral hepatitis serologies, and ultrasound showing an enlarged heterogeneous liver without biliary obstruction, which test, if any, should be performed at this stage to establish the diagnosis?
What is the diagnosis and appropriate treatment for a 33-year-old alcoholic male who wants to stop drinking and presents with anemia, severe thrombocytopenia, hyperbilirubinemia, low albumin, an AST/ALT ratio greater than 2, and a cholestatic pattern of liver enzymes?
What is the practical utility of serum interleukin‑6 (IL‑6) levels in diagnosing and managing neonatal sepsis?
What is the next dose of vilazodone (40 mg orally daily) if dose escalation is needed?
Is there a diagram illustrating the hippocampal memory circuit (trisynaptic pathway)?
What are the causes of green-colored serum?
What is the appropriate order for a therapeutic paracentesis for moderate-to-large ascites secondary to alcoholic liver failure in a 45‑65‑year‑old adult with Child‑Pugh B/C cirrhosis?
What does an N‑terminal pro‑B‑type natriuretic peptide (NT‑proBNP) level of 3093 pg/mL indicate?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.